A dot-enzyme-linked immunosorbent assay (ELISA) using protein A-peroxidase was evaluated as a diagnostic test for canine leishmaniasis. The test results were in agreement with parasitologic diagnosis and indirect immunofluorescence assay results. The sensitivity of the test calculated on 31 dogs with positive parasitologic examination was 90% when a titer of 1/800 was established as a cutoff and 100% when a titer of 1/400 was established. The specificity calculated on the canine population from nonendemic areas was 100% when both titers were established. Nevertheless, in endemic areas titers near the cutoff need careful interpretation. The results of this study demonstrate that dot-ELISA protein A using a bio-dot apparatus is highly suitable for seroepidemiologic field work.
Abstract.
A dot-enzyme-linked immunosorbent assay (ELISA) using protein A-peroxidase was evaluated as a diagnostic test for canine leishmaniasis. The test results were in agreement with parasitologic diagnosis and indirect immunofluorescence assay results. The sensitivity of the test calculated on 31 dogs with positive parasitologic examination was 90% when a titer of 1/800 was established as a cutoff and 100% when a titer of 1/400 was established. The specificity calculated on the canine population from nonendemic areas was 100% when both titers were established. Nevertheless, in endemic areas titers near the cutoff need careful interpretation. The results of this study demonstrate that dot-ELISA protein A using a bio-dot apparatus is highly suitable for seroepidemiologic field work.
Canine leishmaniasis is endemic throughout the Mediterranean basin. The disease is caused by the same parasite as that causing human leishmaniasis, Leishmania infantum. 17 The domestic dog and the European fox (Vulpes vulpes) are incriminated as being the main reservoir of the parasite. 1, 16, 22 The clinical features of canine leishmaniasis vary widely. The 3 major symptoms are depilation, onycogryphosis, and emaciation, and their observation in an endemic area strongly suggests leishmaniasis. 3 Nevertheless, because of the variability of the symptoms and the high frequency of asymptomatic or oligosymptomatic dogs in endemic areas, 2,10 the clinical diagnosis of the disease is difficult.
A definitive diagnosis of leishmaniasis is established by direct observation of the intracellular stage of the parasite in bone marrow, lymph node aspirates, or skin lesions. The conventional parasitologic methods of diagnosis have low sensitivity; 2,15 their usefulness is limited by the number of parasites in the target organs, contamination of cultures, and the ability of strains to grow in vitro. For effective screening of infected dogs, it is necessary to adopt a simple, sensitive, and specific diagnostic test.
Indirect immunofluorescence assay (IFA) is one of the most commonly used immunologic tests for the detection of L. infantum infections in humans and in the dog reservoir, 2,14 but its application requires a high level of skill and experience and large laboratory facilities.
In 1983, a dot enzyme-linked immunosorbent assay (ELISA) for the serologic diagnosis of visceral human leishmaniasis was described as a rapid and economical method that was as sensitive, specific, and reproducible as the more time-consuming ELISA procedure. 18 The test has been used 4, 8, 11, 12 in the diagnosis of human visceral leishmaniasis in the Old World and the diagnosis of cutaneous and mucocutaneous human leishmaniasis and canine visceral leishmaniasis in the New World.
In this paper, we report a similar dot-ELISA for the serodiagnosis of canine leishmaniasis following a previously described procedure. 19 Modifications introduced in this assay, like the use of a polyvalent conjugate as protein A and the use of a bio-dot apparatus to simplify the manipulation, resulted in a simple, highly specific, and sensitive test. The test has long been used in our laboratory in different seroepidemiologic studies on dogs from endemic leishmaniasis areas, from nonendemic areas and from veterinary clinics. 5, 6, 23 
Materials and methods
Animals and samples. The canine sera tested were obtained from 127 dogs from the leishmaniasis focus of Priorat (Catalonia, Spain). Other serum samples included were taken from 37 dogs with other confirmed infectious diseases; i.e., ehrlichiosis (18) , distemper (15) coronavirus and parvovirus (4), from other endemic leishmaniasis areas in Catalonia. Eighty sera from dogs from nonendemic leishmaniasis areas were also included: Tenerife Island (Canary Island, Spain) (26), Switzerland (19) and Sweden (35). Lymph node aspirates from 107 dogs from the Priorat focus were examined by Giemsa staining and cultured in NNN (Novy-McNeal-Nicolle) biphasic blood agar medium. In addition, 59 blood samples of these dogs were collected on filter paper.
All blood and serum samples were tested by dot-ELISA. Seventy samples from animals from the Priorat area were tested by both dot-ELISA and IFA. Blood samples were obtained by puncture of the cephalic vein. Serum was separated and frozen at -40 C until required. Blood samples collected on filter paper were dried and stored at -40 C until required. For use in a dot-ELISA, a 6-mm-diameter circle of blood-soaked paper was cut and eluted with 250 µl of 20 mM Tris, 0.13 mM NaCl (TS) (pH 7.6) containing 0.05% Tween 20 (TST) and 1% dry skimmed milk by shaking for 1 hr. The resulting serum concentration was 1/100. Antigen preparation. Leishmania infantum (MCAN/ES/ 84/BCN-3 ZMON-1) promastigotes, isolated from a naturally infected dog (Priorat, Spain), were used as the source of antigen. Mass culture-parasites in NNN medium were washed by centrifugation using hypotonic saline solution (0.3% NaCl) and physiological saline solution (0.9% NaCl). Parasites were resuspended at a concentration of 2 x 10 6 promastigotes/ml in phosphate-buffered saline (PBS), (pH 7.2) for IFA and 2 x 10 5 promastigotes/µl in 1.5% formalin TS for dot-ELISA. Antigen was stored at 4 C until required.
Dot-ELISA. Nitrocellulose membranes (pore size = 0.45 µm) were cut into 9-x 12-cm sections. The entire membrane was prewetted, immersed in TS for 5 min at room temperature, and dried at 37 C for 45 min. To simplify manipulation, the following steps were performed with the membrane placed in a bio-dot apparatus. a For antigen adsorption, promastigotes fixed in 1.5% formalin TS were dotted onto the nitrocellulose membrane in 1-µl volumes with a syringe dispenser b and dried for 1 hr at 37 C. The antigen membrane was blocked for 30 min at 37 C with 5% skimmed milk solution in TST by shaking. The blocking solution was discarded, and the membrane was washed in TS. The nitrocellulose antigen membrane (NCAM) was stored at -40 C until used.
To perform the test, the NCAM was allowed to reach ambient temperature and placed in the bio-dot apparatus. Previous studies performed using this apparatus following the manufacturer's recommendations (filtering liquids through the membrane) gave strong background, which made the results difficult to read. Therefore, the bio-dot apparatus was used with a plastic film under the NCAM. Fifty microliters of serially diluted serum samples (from 1/100) in 1% skimmed milk TST was added to each well and incubated at 37 C for 30 min. Serum dilutions were discarded, and the plate was washed twice in 100 µl of TST solution and once in 100 µl of TS solution, with 5 min shaking during each wash. The washing solution was removed, and 50 µl of a dilution of horseradish peroxidase-labeled protein A c was added to each well and incubated for 45 min at 37 C. The optimum dilution of the conjugate was 1/2,000 in 1% skimmed milk TST. After removing the conjugate, the NCAM was removed from the bio-dot apparatus and washed by shaking (2 TST, 1 TS, 1 TS 500 mM, 5 min each). The precipitable chromogen 4-chloro-1-naphthol d was dissolved in anhydrous methanol (stock solution, 3 mg/ml) and stored in a dark bottle at 4 C. Immediately before use, 8 ml of 500 mM TS, 2 ml of the chromogen stock solution, and 2 µl of 30% H 2 O 2 were mixed, poured onto the NCAM, and incubated by shaking at room temperature for 10 min. The reaction was stopped by immersion in tap water.
Positive and negative control sera and reagent controls were routinely included in all experiments. Positive reactions appeared as blue dots on a white background, which were easily read by eye ( Fig. 1) .
Indirect immunofluorescence assay. The IFA was carried out as previously described. 14 Canine test sera that had been 2-fold serially diluted in PBS, 1/10-1/1,280, were incubated, and antibodies were stained with the corresponding fluorescein isothiocyanate-labeled anti-IgG (H + L) conjugate e diluted 1/10 in PBS. On the basis of results previously obtained in canine samples, 20 including confirmed cases and endemic control dogs, a titer of ≥ 1/80 was considered to be indicative of Leishmania infection.
Culture. Popliteal lymph node aspirates were inoculated into NNN medium. Cultures were maintained at 26 C, examined on day 7, and passaged 4 times (every week) before being considered negative.
Results
Comparison of dot-ELISA and IFA. The end point titers of the 70 canine sera studied by both techniques are shown in Fig. 2 . Most of the sera that reached the IFA cutoff value of 1/80 attained the titer 1/800 by dot-ELISA. Statistical analysis using the Kendall test showed a significant association between the 2 serologic tests ( = 0.815, P < 0.05). The concordance in seropositivity between both tests was high: 96% when the cutoff was established at 1/400 and 94% when it was established at 1/800.
Comparison of dot-ELISA and parasitologic examination. Results of the dot-ELISA and the para- Table 1 . Leishmania was found in 50% (37%-63%) of animals that gave dot-ELISA values ranging from 1/800 to ≥ 1/6,400, but it was detected in only 12% (3%-33%) of the animals with 1/400 titer and in none of the animals with lower titers.
Sensitivity and specificity of dot-ELISA. Dot-ELISA sensitivity was calculated for 31 dogs with leishmaniasis confimed by parasitologic examination (Table 1) . Specificity was calculated for the canine population from nonendemic areas (dot-ELISA results: 63/80 negative; 11/80 titer 1/100, 6/80 titer 1/200, 0/80 titer ≥ 1/400) Sensitivity and specificity were high: 100% and 100%, respectively, when the cutoff was established at 1/400 dilution and 90% and 100%, respectively, when it was established at 1/800.
Anti-Leishmania antibodies detected by dot-ELISA in dogs with other infectious diseases. Results from the 37 dogs with other infectious diseases are shown in Table 2 . Four of 37 dogs had dot-ELISA titers > 1/ 800, and 6/37 exhibited low titers (1/100-1/400). Because it was not possible to obtain data on the clinical or parasitologic status of these dogs and because they came from leishmaniasis endemic areas, the possibility of these being true-positive sera cannot be ruled out.
Anti-Leishmania antibody titers detected in blood dried on filter paper and in serum samples. Dot-ELISA results of sera and eluates of blood filter papers from 59 dogs are shown in Fig. 3 . Of the samples from 59 dogs, 41 (69%) showed the same titer in both experiments, 17 (29%) differed by 1 dilution, and only 1 sample (2%) differed by 2 dilutions. Thus, considering 1 dilution reading difference to be acceptable, this fluctuation was considered not relevant. Statistical analysis using the Kendall test showed a significant association = 0.906, P < 0.05).
Discussion
The dot-ELISA test for the serodiagnosis of canine leishmaniasis has technical advantages over other methods currently used such as ELISA and IFA. The dot-ELISA is easy to perform, needs only a simple apparatus and minute amounts of reagents, and obviates the need for spectrophotometric readings or a fluorescence microscope, and the results remain readable for a long time. Such aspects make this technique appropriate for field work or small laboratories. The test can be performed in 1.5 hours.
Antigen is 1 of the main limiting factors in an immunoassay. As in other protozoologic diseases, the use of the whole parasite as antigen for the serodiagnosis of leishmaniasis has advantages over the use of soluble antigens, which is why IFA has long been the technique of reference in spite of its technical shortcomings, such as the need for expensive laboratory apparatus, difficulties of automatization, subjective readings, etc. In this dot-ELISA technique and in IFA, antigen is easy to prepare and to standarize; parasites are recovered from culture, washed, and fixed in formaldehyde so- lution. This procedure does not introduce variations in the qualitative or quantitative composition of the antigen, so results obtained by different laboratories are easy to compare. Moreover, in this crude whole antigen, the structure of the molecules is not modified by the use of detergents or reducing agents. The comparison of results obtained with dot-ELISA and with IFA gives a significant association between the techniques = 0.815, P > 0.05). The dot-ELISA technique makes it possible to work with highly diluted sera, which avoids lack of specificity and permits the use of dried blood on filter paper for diagnosis, which is a great advantage during field work and for the storage and mailing of samples to the laboratory. Dot-ELISA titers did not change when dried blood on filter paper samples were stored from -20 C to 25 C for 6 weeks. 24 The use of protein A labeled with peroxidase instead of an anti-dog second antibody allows the test to be used in endemic areas to analyze sera from humans and other possible reservoirs, such as foxes, cats, and other animal species whose immunoglobulins have affinity for protein-A.
The cutoff value for a serologic reaction is the result of a compromise between the sensitivity and the specificity desired for the test. By reducing the cutoff value, the sensitivity of the test could be increased at the risk of reducing specificity. The titer of 1/800 was chosen as the cutoff indicating evolutive leishmaniasis, although 100% specificity and 100% sensitivity were achieved with a cutoff of 1/400. Only a small number of animals with a dot-ELISA titer of 1/400 were positive on direct examination and the lymph node aspirate culture (Table 2) , a number lower (x 2 = 4.4, P < 0.05) than that obtained when the next titer (1/800) was considered.
Serologic studies performed with this dot-ELISA technique in leishmaniasis endemic and nonendemic areas in Spain demonstrated that in endemic areas a large number of asymptomatic dogs have low anti-Leishmania antibody titers, from 1/100 to 1/400, these titers do not occur in places where leishmaniasis is absent or where there is a low endemicity. 7,23 Longterm monitoring of these animals indicates that the low titers may reflect several situations: the prepatent period of the disease, which may last from a few months to several years; 9,13,15 abortive or regressive forms; 15,21 low humoral immunoresponse of the animal; and different host-parasite contacts without establishment of the parasite because of natural resistence of the host, lack of infectivity of the Leishmania strain, or too small an inoculum. There is continued need to develop titers are found with the serologic techniques currently used.
